Faced with in­tense in­vestor back­lash, Unilever now says $68B is its fi­nal of­fer for GSK con­sumer health­care busi­ness

In an an­ti-cli­mat­ic end to a bud­ding takeover fight, Unilever has all but giv­en up on a buy­out of Glax­o­SmithK­line’s con­sumer health­care busi­ness.

Unilever, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER